Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity

por Werner, Milton H., Olanow, C. Warren
Publicado 2021

A New Approach to the Development of Disease‐Modifying Therapies for PD; Fighting Another Pandemic

por Kieburtz, Karl, Katz, Russell, McGarry, Andrew, Olanow, C. Warren
Publicado 2020

Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease

por Chu, Yaping, Bartus, Raymond T, Manfredsson, Fredric P, Olanow, C Warren, Kordower, Jeffrey H
Publicado 2020

Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study

por McGarry, Andrew, Leinonen, Mika, Kieburtz, Karl, Geva, Michal, Olanow, C. Warren, Hayden, Michael
Publicado 2020

Opicapone Pharmacokinetics and Effects on Catechol-O-Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa

por LeWitt, Peter, Liang, Grace S., Olanow, C. Warren, Kieburtz, Karl D., Jimenez, Roland, Olson, Kurt, Klepitskaya, Olga, Loewen, Gordon
Publicado 2023

A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease

por Stocchi, Fabrizio, Peckham, Elizabeth L., De Pandis, Maria Francesca, Sciarappa, Ken, Kleiman, Robert, Agbo, Felix, Olanow, C. Warren, Blum, David, Navia, Bradford
Publicado 2022

Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized Study

por Olanow, C. Warren, Espay, Alberto J., Stocchi, Fabrizio, Ellenbogen, Aaron L., Leinonen, Mika, Adar, Liat, Case, Ryan J., Orenbach, Shir Fuchs, Yardeni, Tami, Oren, Sheila, Poewe, Werner
Publicado 2021

Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease

por Berg, Daniela, Postuma, Ronald B, Bloem, Bastiaan, Chan, Piu, Dubois, Bruno, Gasser, Thomas, Goetz, Christopher G, Halliday, Glenda M, Hardy, John, Lang, Anthony E, Litvan, Irene, Marek, Kenneth, Obeso, José, Oertel, Wolfgang, Olanow, C Warren, Poewe, Werner, Stern, Matthew, Deuschl, Günther
Publicado 2014

Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND Study

por Poewe, Werner, Stocchi, Fabrizio, Arkadir, David, Ebersbach, Georg, Ellenbogen, Aaron L., Giladi, Nir, Isaacson, Stuart H., Kieburtz, Karl, LeWitt, Peter, Olanow, C. Warren, Simuni, Tanya, Thomas, Astrid, Zlotogorski, Abraham, Adar, Liat, Case, Ryan, Oren, Sheila, Fuchs Orenbach, Shir, Rosenfeld, Olivia, Sasson, Nissim, Yardeni, Tami, Espay, Alberto J.
Publicado 2021